|
Volumn 11, Issue 3, 2002, Pages 168-174
|
Anti-adenosine deaminase antibodies in lupus erythematosus
|
Author keywords
Adenosine deaminase; Lupus erythematosus
|
Indexed keywords
ADENOSINE DEAMINASE;
ADENOSINE DEAMINASE ANTIBODY;
ENZYME ANTIBODY;
UNCLASSIFIED DRUG;
ADULT;
ARTICLE;
CELL VIABILITY;
CONTROLLED STUDY;
CORRELATION ANALYSIS;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FEMALE;
HEP 2 CELL;
HUMAN;
IMMUNE DEFICIENCY;
IMMUNOBLOTTING;
IMMUNOFLUORESCENCE;
IMMUNOHISTOCHEMISTRY;
LUPUS ERYTHEMATOSUS;
LYMPHOCYTE COUNT;
LYMPHOCYTOPENIA;
MAJOR CLINICAL STUDY;
MALE;
PATHOGENESIS;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
ADENOSINE DEAMINASE;
ADULT;
AFRICAN AMERICANS;
AUTOANTIBODIES;
CELL LINE;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
EUROPEAN CONTINENTAL ANCESTRY GROUP;
FEMALE;
FLOW CYTOMETRY;
HUMANS;
IMMUNOBLOTTING;
LUPUS ERYTHEMATOSUS, SYSTEMIC;
LYMPHOPENIA;
MALE;
MICROSCOPY, FLUORESCENCE;
MIDDLE AGED;
|
EID: 0036216487
PISSN: 09612033
EISSN: None
Source Type: Journal
DOI: 10.1191/0961203302lu162oa Document Type: Article |
Times cited : (4)
|
References (36)
|